Dopamine And NotClaudio Da Cunha
List of bibliographic references
Number of relevant bibliographic references: 20.Ident. | Authors (with country if any) | Title |
---|---|---|
001995 | Marina E. Emborg [États-Unis] ; Nicole Deglon [Suisse] ; Liza Leventhal [États-Unis] ; Patrick Aebischer [Suisse] ; Jeffrey H. Kordower [États-Unis] | Viral vector-mediated gene therapy for Parkinson's disease |
001997 | J. N. Joyce [États-Unis] ; H. Ryoo [États-Unis] ; E. V. Gurevich [États-Unis] ; C. Adler [États-Unis] ; T. Beach [États-Unis] | Ventral striatal D3 receptors and Parkinson's Disease |
001A04 | Stéphane Hunot [France] ; Andreas Hartmann [France] ; Etienne C. Hirsch [France] | The inflammatory response in the Parkinson brain |
001A84 | Masashi Kitazawa [États-Unis] ; Vellareddy Anantharam [États-Unis] ; Anumantha G. Kanthasamy [États-Unis] | Dieldrin-induced oxidative stress and neurochemical changes contribute to apoptopic cell death in dopaminergic cells |
001C24 | H. M Schipper [Canada] | Heme oxygenase-1: role in brain aging and neurodegeneration |
001D20 | Jean Louis Montastruc [France] ; Olivier Rascol [France] ; Jean-Michel Senard [France] | Treatment of Parkinson's disease should begin with a dopamine agonist |
001E08 | Rowena E. Johnston [États-Unis] ; Jill B. Becker [États-Unis] | Behavioral changes associated with grafts of embryonic ventral mesencephalon tissue into the striatum and/or substantia nigra in a rat model of Parkinson’s Disease |
002009 | Anumantha G. Kanthasamy [États-Unis] ; Arthi Kanthasamy [États-Unis] ; Rae R. Matsumoto [États-Unis] ; Toan Q. Vu [États-Unis] ; Daniel D. Truong [États-Unis] | Neuroprotective effects of the strychnine-insensitive glycine site NMDA antagonist ( R )-HA-966 in an experimental model of Parkinson's disease |
002140 | Michael S. Cousins [États-Unis] ; John D. Salamone [États-Unis] | Skilled motor deficits in rats induced by ventrolateral striatal dopamine depletions: behavioral and pharmacological characterization |
002212 | Manfred Gerlach [Allemagne] ; Wieland Gsell [Allemagne] ; Johannes Kornhuber [Allemagne] ; Kurt Jellinger [Autriche] ; Verena Krieger [Autriche] ; Felix Pantucek [Autriche] ; Reinhard Vock [Allemagne] ; Peter Riederer [Allemagne] | A post mortem study on neurochemical markers of dopaminergic, GABA-ergic and glutamatergic neurons in basal ganglia-thalamocortical circuits in Parkinson syndrome |
002283 | F. Thibaut [France] ; B. A. Faucheux [France] ; J. Marquez [France] ; J. Villares [France] ; J. F. Menard [France] ; Yves Agid [France] ; E. C. Hirsch [France] | Regional distribution of monoamine vesicular uptake sites in the mesencephalon of control subjects and patients with Parkinson's disease: a postmortem study using tritiated tetrabenazine |
002337 | Irit Gordon [Israël] ; Ronit Weizman [Israël] ; Ella Rosenne [Israël] ; Moshe Rehavi [Israël] | Developmental and age-related alterations in rat brain presynaptic dopaminergic mechanisms |
002346 | A. Espino [Espagne] ; J. Llorens [Espagne] ; M. Calopa [Espagne] ; R. Bartrons [Espagne] ; E. Rodriguez-Farre [Espagne] ; S. Ambrosio [Espagne] | Cerebrospinal dopamine metabolites in rats after intrastriatal administration of 6-hydroxydopamine or 1-methyl-4-phenylpyridinium ion |
002419 | K. Shannak ; A. Rajput [Canada] ; B. Rozdilsky [Canada] ; S. Kish ; J. Gilbert [Canada] ; O. Hornykiewicz | Noradrenaline, dopamine and serotonin levels and metabolism in the human hypothalamus: observations in Parkinson's disease and normal subjects |
002424 | Stéphane Lehéricy [France] ; Jean-Philippe Brandel [France] ; Etienne C. Hirsch [France] ; Philippe Anglade [France] ; Joao Villares [France] ; Daniel Scherman [France] ; Charles Duyckaerts [France] ; France Javoy-Agid [France] ; Yves Agid [France] | Monoamine vesicular uptake sites in patients with Parkinson's disease and Alzheimer's disease, as measured by tritiated dihydrotetrabenazine autoradiography |
002442 | H. Ikeda [Royaume-Uni] ; G. M. Head [Royaume-Uni] ; C. J K. Ellis [Royaume-Uni] | Electrophysiological signs of retinal dopamine deficiency in recently diagnosed Parkinson's disease and a follow up study |
002563 | Ruey-Meei Wu [Taïwan, États-Unis] ; Chuang C. Chiueh [États-Unis] ; Agu Pert [États-Unis] ; Dennis L. Murphy [États-Unis] | Apparent antioxidant effect of l-deprenyl on hydroxyl radical formation and nigral injury elicited by MPP+ in vivo |
002653 | Dwaine F. Emerich [États-Unis] ; Shelley R. Winn [États-Unis] ; Lisa Christenson [États-Unis] ; Meg A. Palmatier [États-Unis] ; Frank T. Gentile [États-Unis] ; Paul R. Sanberg [États-Unis] | A novel approach to neural transplantation in Parkinson's disease: Use of polymer-encapsulated cell therapy |
002784 | J. S. Schneider [États-Unis] ; C. J. Kovelowski Ii [États-Unis] | Chronic exposure to low doses of MPTP. I. Cognitive deficits in motor asymptomatic monkeys |
002A04 | S. Kaakkola [Finlande] ; P. T. M Nnistö [Finlande] ; E. Nissinen [Finlande] ; A. Vuorela [Finlande] ; R. M Ntyl [Finlande] | The effect of an increased ratio of carbidopa to levodopa on the pharmacokinetics of levodopa |
This area was generated with Dilib version V0.6.23. |